BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6185783)

  • 1. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Walker C; Taylor SH
    Int J Cardiol; 1984 Mar; 5(3):317-25. PubMed ID: 6706437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma concentrations and pharmacological effects of labetalol.
    Richards DA; Maconochie JG; Bland RE; Hopkins R; Woodings EP; Martin LE
    Eur J Clin Pharmacol; 1977 Jan; 11(2):85-90. PubMed ID: 14010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G
    Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
    Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
    J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.
    Taylor SH; Silke B; Nelson GI; Okoli RC; Ahuja RC
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):325-7. PubMed ID: 6807469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
    Meretoja OA; Allonen H; Arola M; Laaksonen VO
    Chest; 1980 Dec; 78(6):810-5. PubMed ID: 7004797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Choudhury S; Taylor SH
    Ir J Med Sci; 1983 May; 152(5):179-86. PubMed ID: 6874287
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.